Sectors
STRO
Sutro Biopharma, Inc.
19.63
2 x 18.57
2 x 31.70
bid
ask
-
0.82
4.01%
03:06 PM
timesize
| Ytd | 69.66% | |
| 1y | 128.26% |
19.46
day range
20.73
7.15
52 week range
43.85
| Open | 20.46 | Prev Close | 20.45 | Low | 19.46 | High | 20.73 | Mkt Cap | 325.82M |
| Vol | 91.43K | Avg Vol | 338.87K | EPS | -17.37 | P/E | N/A | Forward P/E | -0.63 |
| Beta | 1.55 | Short Ratio | 2.47 | Inst. Own | 77.14% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 25.55 | 200-d Avg | 21.96 | 1yr Est | 11.50 |
| Income Statement | |||
| Total Revenue | 9.84M | ||
| Revenues (USD) | 9.84M | ||
| Gross Profit | 9.84M | ||
| Operating Expenses | 39.73M | ||
| Research and Development Expense | 31.70M | ||
| Selling, General and Administrative Expense | 7.83M | ||
| Operating Income | -29.89M | ||
| Interest Expense | 505.00K | ||
| Income Tax Expense | 1000 | ||
| Net Income | -38.53M | ||
| Net Income Common Stock | -38.53M | ||
| Net Income Common Stock (USD) | -38.53M | ||
| Consolidated Income | -38.53M | ||
| Earnings per Basic Share | -2.33 | ||
| Earnings per Basic Share (USD) | -2.33 | ||
| Earnings per Diluted Share | -2.33 | ||
| Earning Before Interest & Taxes (EBIT) | -38.03M | ||
| Earning Before Interest & Taxes (USD) | -38.03M | ||
| Weighted Average Shares | 16.57M | ||
| Weighted Average Shares Diluted | 16.57M | ||
| Balance Sheet | |||
| Cash and Equivalents | 55.19M | ||
| Cash and Equivalents (USD) | 55.19M | ||
| Investments | 110.01M | ||
| Investments Current | 110.01M | ||
| Trade and Non-Trade Receivables | 5.80M | ||
| Current Assets | 175.65M | ||
| Property, Plant & Equipment Net | 16.82M | ||
| Total Assets | 194.46M | ||
| Debt Current | 6.66M | ||
| Total Debt | 10.78M | ||
| Current Liabilities | 52.90M | ||
| Debt Non-Current | 4.12M | ||
| Total Liabilities | 297.78M | ||
| Accumulated Retained Earnings (Deficit) | -1.05B | ||
| Accumulated Other Comprehensive Income | -58.00K | ||
| Shareholders Equity | -103.32M | ||
| Shareholders Equity (USD) | -103.32M | ||
| Assets Non-Current | 18.82M | ||
| Total Debt (USD) | 10.78M | ||
| Deferred Revenue | 6.46M | ||
| Liabilities Non-Current | 244.88M | ||
| Trade and Non-Trade Payables | 3.36M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.50M | ||
| Net Cash Flow from Financing | -418.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -19.35M | ||
| Issuance (Purchase) of Equity Shares | -418.00K | ||
| Net Cash Flow from Investing | 19.36M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 19.36M | ||
| Net Cash Flow from Operations | -38.29M | ||
| Share Based Compensation | 2.01M | ||